CRNX vs PTGX
Crinetics Pharmaceuticals, Inc. · Protagonist Therapeutics, Inc.
Relative return (rebased to 100)
Key stats
| Metric | CRNX | PTGX |
|---|---|---|
| Price | $84.95 | $145.07 |
| Market Cap | $9.01B | $9.39B |
| P/E | — | — |
| P/B | 7.56 | 11.15 |
| P/S | 1170.77 | 204.00 |
| ROE | -39.0% | -15.5% |
| Net Margin | -6046.2% | -282.8% |
| Gross Margin | — | — |
| Revenue Growth | 640.7% | -89.4% |
| Dividend Yield | — | — |
| EPS | -$4.39 | -$2.01 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.